BlackRock Group’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.2M | Buy |
110,810
+24,288
| +28% | +$262K | ﹤0.01% | 2033 |
|
|
2016
Q3 | $887K | Buy |
86,522
+3,289
| +4% | +$33.7K | ﹤0.01% | 2076 |
|
|
2016
Q2 | $1.09M | Buy |
83,233
+2,994
| +4% | +$39.1K | ﹤0.01% | 1924 |
|
|
2016
Q1 | $883K | Buy |
80,239
+6,199
| +8% | +$68.2K | ﹤0.01% | 1989 |
|
|
2015
Q4 | $680K | Sell |
74,040
-326
| -0.4% | -$2.99K | ﹤0.01% | 2070 |
|
|
2015
Q3 | $516K | Buy |
74,366
+2,637
| +4% | +$18.3K | ﹤0.01% | 2177 |
|
|
2015
Q2 | $704K | Buy |
71,729
+41,436
| +137% | +$407K | ﹤0.01% | 2122 |
|
|
2015
Q1 | $268K | Buy |
30,293
+3,885
| +15% | +$34.4K | ﹤0.01% | 2385 |
|
|
2014
Q4 | $232K | Hold |
26,408
| – | – | ﹤0.01% | 2471 |
|
|
2014
Q3 | $182K | Buy |
26,408
+24,722
| +1,466% | +$170K | ﹤0.01% | 2465 |
|
|
2014
Q2 | $9K | Hold |
1,686
| – | – | ﹤0.01% | 2770 |
|
|
2014
Q1 | $8K | Hold |
1,686
| – | – | ﹤0.01% | 2692 |
|
|
2013
Q4 | $8K | Sell |
1,686
-91,504
| -98% | -$434K | ﹤0.01% | 2614 |
|
|
2013
Q3 | $473K | Buy |
93,190
+91,504
| +5,427% | +$464K | ﹤0.01% | 2233 |
|
|
2013
Q2 | $8K | Buy |
+1,686
| New | +$8K | ﹤0.01% | 2561 |
|